- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Richard Lindstrom, MD: "Building" on ophthalmic innovation
Listen as Gil Kliman, MD, managing director of InterWest Partners, interviews Richard Lindstrom, MD, in a one-on-interview at the 2014 Glaucoma 360 meeting. Dr. Lindstrom recalls how he was primed as a boy for the construction business by his father, but decided to go to medical school. The decision catapulted Dr. Lindstrom’s career as ophthalmologist, surgeon, and product innovator.
Richard Lindstrom, MD, (right) discusses ophthalmic innovations with Gil Kilman, MD, during their one-on-one interview. (Photo by Stevan Nordstrom)“I’m probably the only person to have a father angry that his son went to medical school,” quipped Richard L. Lindstrom, MD. As part of a one-on-one interview with Gil Kliman, MD, managing director of InterWest Partners, Dr. Lindstrom recalled how he was primed as a boy for the construction business by his father, before medicine chose him during an honors student mentorship at the University of Minnesota. Dr. Lindstrom was persuaded to go to medical school. The decision catapulted Dr. Lindstrom’s career as ophthalmologist, surgeon, and product innovator. Listen to Dr. Kliman’s interview with ophthalmology’s most innovative and influential opinion leader. Listen to Dr. Kliman's complete interview with Dr. Lindstrom. Also, watch as Dr. Lindstrom discusses the advancements in glaucoma over his 40-year career in ophthalmology.
